From the National Institutes of Health.
Raub
W
W
National Institutes of Health, Bethesda, MD 20892.
D000855:Anorexia / Q000188:drug therapy*; D002100:Cachexia / Q000188:drug therapy*; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D005357:Fibrous Dysplasia of Bone / Q000235:genetics*; D005359:Fibrous Dysplasia, Polyostotic / Q000235:genetics*; D019204:GTP-Binding Proteins / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008264:Macrophages / Q000187:drug effects*; D008535:Megestrol / Q000627:therapeutic use; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy*; D014481:United States; D015215:Zidovudine / Q000494:pharmacology
D015215:Zidovudine; D008535:Megestrol; D019204:GTP-Binding Proteins